证券代码：600135 证券简称：乐凯胶片 公告编号：2023-045 详见公司同日发布的《乐凯胶片股份有限公司 2023 年半年度报告》及其摘 要。 同意 9 票、反对 0 票、弃权 0 票，表决通过。 二、关于公司 2023 年半年度募集资金存放与实际使用情况专项报告的议案 详见公司同日发布的《乐凯胶片股份有限公司 2023 年半年度募集资金存放 与实际使用情况专项报告》。 同意 9 票、反对 0 票、弃权 0 票，表决通过。 三、关于对航天科技财务有限责任公司的 2023 年半年度风险评估报告的议 案 乐凯胶片股份有限公司 九届六次董事会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 乐凯胶片股份有限公司（以下简称"公司"）第九届董事会第六次会议通知 于 2023 年 8 月 11 日以邮件和电话的方式发出，会议于 2023 年 8 月 23 日在办公 楼会议室现场召开，会议应到董事 9 人，实到董事 8 人，董事路建波因工作原因 未能出席，已委托董事张永光出席并代为行使表决权，会议由公司董事长王洪泽 先生主持。公司监事和高级管理人 ...

证券代码：600135 证券简称：乐凯胶片 公告编号：2023-043 乐凯胶片股份有限公司 变更部分募集资金投向收购乐凯光电材料有限公司 100%股权 的进展公告 公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假记载、 误导性陈述或者重大遗漏负连带责任。 一、 交易概述 乐凯胶片股份有限公司（以下简称"公司"）于 2023 年 7 月 17 日召开了第九届 董事会第四次会议，会议审议并一致通过了《关于变更部分募集资金投向收购乐凯 光电材料有限公司 100%股权的关联交易议案》和《关于收购乐凯光电材料有限公 司 100%股权后，变更部分募集资金投向对其增资的关联交易议案》。公司拟变更部 分募集资金用途，向中国乐凯集团有限公司（以下简称"中国乐凯"）收购乐凯光电 材料有限公司（以下简称"乐凯光电"）100%股权并对其增资进行项目建设。详见公 司于 2023 年 7 月 18 日披露的《乐凯胶片股份有限公司关于变更部分募集资金投资 项目的公告》（公告编号：2023-038），和《乐凯胶片股份有限公司收购乐凯光电材 料有限公司 100%股权并增资的关联交易公告》（公告编号：2023-039）。 二、 ...

证券代码：600135 证券简称：乐凯胶片 公告编号：2023-029 公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚假 记载、误导性陈述或者重大遗漏负连带责任。 重要内容提示： 会议召开时间：2023 年 06 月 12 日(星期一) 下午 16:00-17:00 乐凯胶片股份有限公司 关于召开 2022 年度业绩说明会的公告 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 06 月 05 日(星期一) 至 06 月 09 日(星期五)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司投资者关系邮箱： stock@luckyfilm.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 乐凯胶片股份有限公司（以下简称"公司"）已于 2023 年 4 月 26 日发布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、 财务状况，公司计划于 2023 年 06 月 12 日 下午 16:00-17: ...

证券代码：600135 证券简称：乐凯胶片 公告编号：2023-028 1 乐凯胶片股份有限公司 关于参加河北辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 为进一步加强与投资者的互动交流，乐凯胶片股份有限公司（以下简称"公 司"）将参加由河北证监局、河北省上市公司协会与深圳市全景网络有限公司联 合举办的"2023 年河北辖区上市公司投资者集体接待日活动"，现将相关事项公 告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参与 本次互动交流，活动时间为 2023 年 5 月 30 日（周二）15:00-17:00。届时公司高 管将在线就公司 2022 年度业绩、公司治理、发展战略、经营状况、融资计划、 股权激励和可持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广 大投资者踊跃参加。 特此公告。 乐凯胶片股份有限公司董事会 2023 年 5 月 25 日 ...

2023 年第一季度报告 证券代码：600135 证券简称：乐凯胶片 乐凯胶片股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同期 增减变动幅度(%) | | --- | --- | --- | | 营业收入 | 492,634,295.49 | -6.73 | | 归属于上市公司股东的净利润 | 1,108,180.87 | -87.47 | | 归属于上市公司股东的扣除非 经常性损益的净利润 | -3,810,470.94 | -200.73 | | 经营活动产生 ...

Financial Performance - In 2022, the company achieved a net profit of CNY 12,044,692.49, with a cash dividend of CNY 0.21 per 10 shares, totaling CNY 11,619,449.08, which accounts for 30.07% of the net profit attributable to shareholders [6]. - The company's operating revenue for 2022 was CNY 2,067,781,111.67, representing a decrease of 7.48% compared to 2021 [24]. - The net profit attributable to shareholders decreased by 28.89% to CNY 38,640,775.77 in 2022 from CNY 54,337,072.76 in 2021 [24]. - The basic earnings per share for 2022 was CNY 0.0698, down 28.92% from CNY 0.0982 in 2021 [24]. - The total profit amounted to 46.96 million RMB, reflecting a decline of 28.54% compared to the previous year [42]. - The company reported a net cash flow from operating activities of CNY 148,570,015.82, an increase of 62.92% compared to CNY 91,189,972.38 in 2021 [24]. - The company achieved a total revenue of 2.0678 billion RMB in 2022, a decrease of 7.48% compared to the previous year [42]. - The company reported a significant increase in financial expenses by 1,370.85% to 2.40 million RMB, mainly due to exchange rate fluctuations [52]. Assets and Liabilities - The total assets of the company at the end of 2022 were CNY 3,499,301,046.13, reflecting a growth of 5.03% from CNY 3,331,741,450.28 at the end of 2021 [24]. - The company’s net assets attributable to shareholders increased by 2.20% to CNY 2,671,700,901.35 at the end of 2022 [24]. - The cash and cash equivalents increased by 18.72% to approximately 806.21 million RMB [59]. - The inventory level increased by 2.73% to approximately 519.67 million RMB [59]. - The company’s fixed assets rose by 30.88% to approximately 506.28 million RMB, driven by the capitalization of the aluminum-plastic film project [59]. Research and Development - The research and development expenses were 105.68 million RMB, down by 6.98% from the previous year [44]. - The total R&D investment accounted for 5.11% of operating revenue, with no capitalized R&D expenditures [54]. - The number of R&D personnel is 141, representing 5.8% of the total workforce [55]. - The company has initiated over 40 R&D projects in the past three years, resulting in 14 patent applications, with 11 patents granted, including 5 invention patents [71]. - The company is focused on developing new products and improving service systems, transitioning from a research and production enterprise to a high-tech service-oriented company [71]. Market and Sales - The international market revenue reached 350 million RMB, showing a significant increase of 54.7% year-on-year [42]. - The company achieved significant breakthroughs in market expansion, with notable increases in export revenues, particularly in industrial radiography films and photovoltaic backsheet products [32]. - The company is focusing on the photovoltaic materials and lithium battery materials sectors, which are experiencing rapid growth [38]. - The company is actively optimizing its marketing model to adapt to rapidly changing market demands [40]. - The company is actively expanding its online sales presence, with monthly sales increasing on platforms like Tmall and Taobao [94]. Environmental and Social Responsibility - The company invested CNY 2.787 million in environmental protection during the reporting period [165]. - The company has established a comprehensive wastewater treatment system with a capacity of 1,750 tons per day [166]. - The company has implemented measures to reduce carbon emissions, including equipment upgrades for energy efficiency [170]. - The company has a robust internal audit and supervision mechanism to promote sustainable development [163]. - The company has not faced any administrative penalties related to environmental issues during the reporting period [168]. Governance and Compliance - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements [121]. - The company has established a sound internal control and risk management system to enhance its ability to mitigate significant risks [121]. - The company ensures the independence and completeness of its assets, with no funds or assets occupied by the controlling party or its subsidiaries [124]. - The company has committed to maintaining independence in its operations, ensuring that key management personnel do not hold positions in related entities [123]. - The company’s annual financial report and budget proposals were approved at the shareholders' meeting, indicating a structured financial governance process [128]. Future Outlook and Strategy - The company plans to expand its market presence and enhance product offerings in the upcoming fiscal year [134]. - New product development initiatives are underway, focusing on innovative technologies to drive growth [135]. - Future guidance suggests a positive outlook with expected revenue growth driven by new product launches and market expansion strategies [135]. - The company aims to enhance its marketing system and achieve annual marketing tasks by closely monitoring industry trends and seizing market opportunities [116]. - The company is actively pursuing mergers and acquisitions to strengthen its market position and diversify its portfolio [134].

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 1,108,020,647.97, a decrease of 4.33% compared to CNY 1,158,187,792.68 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2022 was CNY 28,535,454.74, down 32.87% from CNY 42,506,334.67 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was CNY 13,742,985.44, a decline of 63.61% compared to CNY 37,762,634.35 in the same period last year[18]. - The basic earnings per share for the first half of 2022 was CNY 0.0516, a decrease of 34.68% from CNY 0.0790 in the previous year[19]. - The total assets at the end of the reporting period were CNY 3,287,581,338.02, a decrease of 1.33% from CNY 3,331,741,450.28 at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were CNY 2,626,065,580.32, an increase of 0.46% from CNY 2,614,129,338.55 at the end of the previous year[18]. - The weighted average return on net assets for the first half of 2022 was 1.0857%, down from 1.6434% in the same period last year, a decrease of 0.5578 percentage points[19]. - The company reported a net cash flow from operating activities of CNY -153,651,585.65, an improvement from CNY -188,709,121.45 in the previous year[18]. - The company's cash and cash equivalents decreased by 55.74% to ¥300,566,215.01, primarily due to increased material procurement expenditures[35]. - The accounts receivable increased by 54.55% to ¥474,339,425.53, reflecting growth in the photovoltaic business[35]. Market and Product Development - The company faced a decrease in sales prices of major products, leading to reduced revenue and net profit[19]. - The company has not disclosed any new product developments or market expansion strategies in this report[18]. - The company focuses on strategic emerging industries, achieving substantial growth in the fields of new energy and new materials, with main products including solar cell backsheets and medical dry films[24]. - In the photovoltaic materials sector, the company has implemented a major client development strategy, resulting in significant progress in both large and small customer segments[24]. - The medical materials sector has seen breakthroughs in the market for medical dry films and industrial radiography films, driven by policy changes and supply chain transformations[25]. - The lithium battery materials industry is experiencing rapid growth, with the company improving product quality and stability through technological advancements and production optimization[25]. - The company has not disclosed any new product developments or technological advancements during the reporting period[58]. Research and Development - The company invests over 3% of its revenue annually in R&D, maintaining a strong focus on independent innovation and holding multiple patents and awards for its technologies[27]. - Research and development expenses for the first half of 2022 were CNY 44,037,489.99, a decrease of 8.1% compared to CNY 47,916,234.60 in the same period of 2021[97]. - Research and development expenses increased to CNY 27,235,908.55, up from CNY 24,411,146.48 in the first half of 2021, indicating a focus on innovation[100]. Environmental Responsibility - The company has a wastewater treatment capacity of 1,750 tons per day and a silver recovery system with a capacity of 750 tons per day[51]. - The company has implemented a comprehensive environmental monitoring plan, including monthly and quarterly assessments of wastewater and air emissions[53]. - The company's wastewater discharge permit specifies limits for COD at 110 mg/l and SO2 at 50 mg/Nm3, ensuring compliance with environmental regulations[55]. - The company has appointed a dedicated environmental protection team to oversee the operation of pollution control facilities and ensure compliance with environmental responsibilities[55]. - The company has completed the emergency response plan for environmental incidents, which is registered and updated regularly[52]. - The company has committed to monitoring environmental factors including wastewater, waste gas, and noise, with specific monitoring frequencies for various pollutants[57]. - The company has not disclosed any additional environmental information or measures taken to reduce carbon emissions during the reporting period[58]. Financial Commitments and Governance - The company has made commitments related to the acquisition of shares in LeKai Film, including a 36-month lock-up period for shares obtained through non-public issuance[60]. - The company ensures the independence of LeKai Film in terms of personnel, assets, and finances, with specific measures to maintain this independence[60]. - The company has committed to maintaining the independence of its financial operations, ensuring no shared bank accounts with the controlling party[62]. - The company guarantees the independence of its organizational structure, with separate operational and production facilities from the controlling party[62]. - The company has established an independent financial department and accounting system to ensure financial autonomy[62]. - The company will not allow any interference from the controlling party in its business operations post-transaction[62]. - The company has pledged to uphold the rights of all shareholders and will not engage in actions that could harm shareholder interests[62]. - The company will support the implementation of employee stock ownership plans linked to performance measures[62]. Operational Risks and Challenges - The company faces operational risks due to fluctuations in raw material supply and prices, as well as changes in market demand and competitive actions[40]. - The company is actively monitoring government policies affecting the solar and lithium battery industries to enhance product profitability and ensure sustainable development[40]. - The photovoltaic industry is experiencing continuous cost reductions, increasing pressure on the company's profitability, while the traditional silver salt imaging materials market is declining rapidly[40]. - The company plans to enhance lithium battery product profitability through various cost-reduction strategies, including optimizing processes and reducing raw material costs[40]. - The company is focusing on developing new businesses in the medical imaging sector to counteract the impact of digital technology on traditional medical film markets[40]. Shareholder Information - As of the end of the reporting period, the total number of ordinary shareholders was 27,008[81]. - The largest shareholder, China Lucky Group Co., Ltd., holds 252,776,443 shares, representing 45.68% of the total shares[82]. - The second largest shareholder, Meishan Pengshan Xincheng Industrial Investment Co., Ltd., decreased its holdings by 17,161,602 shares to 37,611,480 shares, which is 6.80%[82]. - The company has 125,542,282 shares under lock-up conditions, which will be released after 36 months[84]. Accounting and Financial Reporting - The financial statements are prepared based on the going concern principle and comply with the accounting standards issued by the Ministry of Finance[129]. - The company has a total of 6 subsidiaries included in the consolidated financial statements[127]. - The accounting period for the company runs from January 1 to December 31 each year[133]. - The company’s accounting policies and estimates are determined based on its operational characteristics and actual circumstances[131]. - The company’s financial statements reflect its financial position, operating results, changes in shareholders' equity, and cash flows accurately and completely[132]. - The company’s business cycle is 12 months, aligning with its accounting period[134]. - The company’s accounting currency is RMB[135].

2022 年第一季度报告 证券代码：600135 证券简称：乐凯胶片 乐凯胶片股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 1 / 11 单位：元 币种：人民币 2022 年第一季度报告 | 项目 | 本报告期 | 本报告期比上年同期增减变 | | --- | --- | --- | | | | 动幅度(%) | | 营业收入 | 528,182,267.85 | -6.93 | | 归属于上市公司股东的净利润 | 8,845,720.97 | -47.30 | | 归属于上市公司股东的扣除非经常性 | 3,782,89 ...

Financial Performance - In 2021, the company's operating revenue reached CNY 2,235,030,946.59, an increase of 8.82% compared to CNY 2,053,825,545.70 in 2020[24] - The net profit attributable to shareholders of the listed company was CNY 54,337,072.76, representing a 45.85% increase from CNY 37,254,282.03 in the previous year[24] - The net profit after deducting non-recurring gains and losses was CNY 14,623,665.68, a significant recovery from a loss of CNY 4,669,050.24 in 2020[24] - The net cash flow from operating activities was CNY 91,189,972.38, up 5.42% from CNY 86,503,640.13 in 2020[24] - The total assets at the end of 2021 were CNY 3,331,741,450.28, an increase of 4.74% from CNY 3,180,814,840.30 in 2020[24] - The net assets attributable to shareholders of the listed company were CNY 2,614,129,338.55, a 1.83% increase from CNY 2,567,110,714.14 in 2020[24] - Basic earnings per share for 2021 were CNY 0.0982, up 44.62% from CNY 0.0679 in 2020[25] - The weighted average return on net assets increased to 2.10% from 1.48% in 2020, an increase of 0.62 percentage points[25] Dividend and Profit Distribution - The company plans to distribute a cash dividend of CNY 0.30 per 10 shares, totaling CNY 16,599,212.97, which accounts for 30.55% of the net profit attributable to shareholders[6] - The company reported a cumulative distributable profit of CNY 153,397,623.65 as of December 31, 2021[6] Revenue and Sales Growth - The sales of dry plates increased by 40.3% year-on-year, with the number of new hospital clients growing by 12%[33] - The lithium battery separator sales surged by 154.2% year-on-year, indicating strong market demand and successful product positioning[34] - The export of color photographic paper increased by 32.8% year-on-year, reflecting successful international market expansion efforts[34] - The sales of industrial films grew by 12.9% year-on-year, demonstrating effective market strategies and product upgrades[33] Research and Development - The company invests over 3% of its revenue annually in R&D, maintaining a robust technological innovation advantage with a focus on core technologies[42] - Research and development expenses increased by 50.86% to approximately 113.61 million RMB due to new R&D projects[46] - The company has initiated over 40 R&D projects in the past three years, resulting in 14 patent applications, including 5 invention patents[72] - The company is accelerating research on new products and fields, completing preliminary project research reports and identifying key project development directions[35] Market Trends and Strategic Focus - The photovoltaic materials market is experiencing a price increase of 21% year-on-year, with expectations for rapid growth as prices of silicon materials stabilize[39] - The medical imaging industry is undergoing significant changes due to policies like two-invoice system and centralized procurement, which are reshaping the supply chain[39] - The lithium battery materials sector is seeing increased demand driven by policies supporting energy storage and the growth of the electric vehicle market[40] - The company plans to continue expanding its market presence and enhancing its product offerings through strategic partnerships and technological innovations[34] Operational Efficiency and Cost Management - The company is enhancing its production efficiency through lean production principles, optimizing process control, and reducing equipment downtime, which contributes to cost management breakthroughs[35] - The company has successfully optimized production processes, leading to significant cost reductions across various product lines[34] - The company emphasizes lean production principles to improve operational efficiency and reduce costs across all business segments[124] Environmental and Safety Management - The company has implemented a comprehensive safety and environmental management strategy, continuously investing in safety measures and risk control[37] - The company has established a dedicated environmental protection organization with clear responsibilities assigned to leadership and departments[174] - The company has committed to fulfilling environmental commitments and has established a monitoring system for environmental facility operations[174] Corporate Governance and Shareholder Rights - The company has a transparent information disclosure system, ensuring timely and accurate information is provided to all shareholders[132] - The company has implemented a registration management system for insiders to prevent insider trading and maintain fair information disclosure[132] - The company ensures the independence of its assets, with no funds or assets being occupied by the controlling shareholder or its subsidiaries[133] Strategic Commitments and Future Outlook - The company committed to maintaining the independence of its operations post-transaction, ensuring that it has independent assets, personnel, qualifications, and capabilities to operate autonomously in the market[184] - The company will adhere to the latest regulatory requirements and provide supplementary commitments if necessary to meet the standards set by the China Securities Regulatory Commission[184] - The company aims to enhance its market competitiveness by focusing on customer satisfaction and integrated market strategies[73]